American Association for the Study of Liver Diseases - The Liver Meeting Digital Experience

UDCA for primary sclerosing cholangitis may lower biliary tract cancer risk

Patients with primary sclerosing cholangitis (PSC) who are treated with ursodeoxycholic acid (UDCA) may have a lower risk of liver transplantation, all-cause death, or biliary tract cancer, according to a study from Japan.